Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.
(2005) 2005 ASCO Annual Meeting In Journal of Clinical Oncology 23(16S). p.841-841
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/226787
- author
- Tanner, MM ; Isola, JJ ; Wiklund, T ; Erikstein, B ; Kellokumpu-Lehtinen, P ; Malmström, Per LU ; Wilking, N ; Nilsson, J and Bergh, J
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 23
- issue
- 16S
- pages
- 841 - 841
- publisher
- American Society of Clinical Oncology
- conference name
- 2005 ASCO Annual Meeting
- conference dates
- 0001-01-02
- external identifiers
-
- wos:000230326605403
- ISSN
- 1527-7755
- language
- English
- LU publication?
- yes
- id
- d82ab9cb-2c82-482b-adf2-93ef72567e1e (old id 226787)
- alternative location
- http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/9518
- date added to LUP
- 2016-04-01 12:25:54
- date last changed
- 2018-11-21 20:07:22
@misc{d82ab9cb-2c82-482b-adf2-93ef72567e1e, author = {{Tanner, MM and Isola, JJ and Wiklund, T and Erikstein, B and Kellokumpu-Lehtinen, P and Malmström, Per and Wilking, N and Nilsson, J and Bergh, J}}, issn = {{1527-7755}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{16S}}, pages = {{841--841}}, publisher = {{American Society of Clinical Oncology}}, series = {{Journal of Clinical Oncology}}, title = {{Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.}}, url = {{http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/9518}}, volume = {{23}}, year = {{2005}}, }